Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review

MI Khan, MI Hossain, MK Hossain… - ACS Applied Bio …, 2022 - ACS Publications
Traditional treatment approaches for cancer involve intravenous chemotherapy or other
forms of drug delivery. These therapeutic measures suffer from several limitations such as …

Surface modification of lipid-based nanocarriers: a potential approach to enhance targeted drug delivery

S Priya, VM Desai, G Singhvi - ACS omega, 2022 - ACS Publications
Nanocarriers have the utmost significance for advancements in drug delivery and
nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based …

Nanoemulsions: Factory for food, pharmaceutical and cosmetics

NAN Azmi, AAM Elgharbawy, SR Motlagh, N Samsudin… - Processes, 2019 - mdpi.com
Nanotechnology, particularly nanoemulsions (NEs), have gained increasing interest from
researchers throughout the years. The small-sized droplet with a high surface area makes …

Current applications of nanoemulsions in cancer therapeutics

E Sánchez-López, M Guerra, J Dias-Ferreira… - Nanomaterials, 2019 - mdpi.com
Nanoemulsions are pharmaceutical formulations composed of particles within a nanometer
range. They possess the capacity to encapsulate drugs that are poorly water soluble due to …

Nanoemulsions in drug delivery: formulation to medical application

HH Tayeb, F Sainsbury - Nanomedicine, 2018 - Taylor & Francis
Nanoscale oil-in-water emulsions (NEs), heterogeneous systems of two immiscible liquids
stabilized by emulsifiers or surfactants, show great potential in medical applications because …

Nanoemulsions in translational research—opportunities and challenges in targeted cancer therapy

S Ganta, M Talekar, A Singh, TP Coleman, MM Amiji - Aaps Pharmscitech, 2014 - Springer
Nanoemulsion dosage form serves as a vehicle for the delivery of active pharmaceutical
ingredients and has attracted great attention in drug delivery and pharmacotherapy. In …

A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer

H Bu, X He, Z Zhang, Q Yin, H Yu, Y Li - International journal of …, 2014 - Elsevier
Paclitaxel resistance is usually developed in clinical chemotherapy, which remains a major
obstacle for successful cancer treatment. Herein, we attempted to develop a TPGS …

A judicious review on the applications of chemotherapeutic loaded nanoemulsions in cancer management

SM Alshahrani - Journal of Drug Delivery Science and Technology, 2022 - Elsevier
The escalating prevalence of cancer, a condition in which uncontrolled cell growth leads to
complications and tissue failure, is one of the major concerns of healthcare professionals …

Sphingolipids in apoptosis

TS Tirodkar, C Voelkel-Johnson - Experimental oncology, 2012 - dspace.nbuv.gov.ua
Forty years ago, the term “apoptosis” was introduced to describe a form of programmed cell
death. Key players that mediate apoptosis at the molecular level such as caspases, death …

GE11-directed functional polymersomal doxorubicin as an advanced alternative to clinical liposomal formulation for ovarian cancer treatment

Y Zou, Y Xia, F Meng, J Zhang… - Molecular Pharmaceutics, 2018 - ACS Publications
Ovarian cancer as a recurrent disease is often refractory to treatment including pegylated
liposomal doxorubicin hydrochloride (Lipo-Dox). Here, GE11 peptide-modified reversibly …